Teva Pharmaceutical issues 2017 guidance that is below expectations – MarketWatch

Teva Pharmaceutical issues 2017 guidance that is below expectations
MarketWatch
Shares of Teva Pharmaceutical Industries TEVA, -7.53% fell more than 5% in premarket trade on Friday after the company issued 2017 guidance that is below Wall Street expectations. Teva forecasts per-share earnings to range from $4.90 to $5.30. Analysts¬†…

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd